Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.
Feldman DR, Kondagunta GV, Ginsberg MS, Ishill N, Patil S, Cestaro J, Obbens E, Sheinfeld J, Bosl GJ, Motzer RJ.
Feldman DR, et al. Among authors: motzer rj.
Invest New Drugs. 2007 Oct;25(5):487-90. doi: 10.1007/s10637-007-9059-2. Epub 2007 May 23.
Invest New Drugs. 2007.
PMID: 17520176
Clinical Trial.